Zobrazeno 1 - 10
of 448
pro vyhledávání: '"Stefan Mauss"'
Autor:
Frank Tacke, Hartwig Klinker, Klaus H. W. Boeker, Uta Merle, Ralph Link, Peter Buggisch, Dietrich Hüppe, Markus Cornberg, Christoph Sarrazin, Heiner Wedemeyer, Thomas Berg, Stefan Mauss, DHC‐R
Publikováno v:
Hepatology Communications, Vol 6, Iss 9, Pp 2488-2495 (2022)
Abstract While direct‐acting antivirals (DAAs) cure chronic hepatitis C virus (HCV) infection in almost all patients, some patients remain at risk of liver disease despite HCV cure. In order to identify risk factors indicating liver‐related morbi
Externí odkaz:
https://doaj.org/article/eab8e1a6a8ec4afaa1c53342e740d275
Autor:
Emily D. Meyer, Sandra Dudareva, Christian Kollan, Stefan Mauss, Heiner Wedemeyer, Daniel Schmidt, Ruth Zimmermann
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
Effectively treating hepatitis C viral (HCV) infections prevents sequelae and onward transmission. In Germany, HCV drug prescriptions have declined since 2015. During the COVID-19 pandemic, lockdowns impacted the access to HCV care services and HCV t
Externí odkaz:
https://doaj.org/article/882aabcf7a0349ddad4d6d71c12232a9
Autor:
Anna Maisa, Christian Kollan, Matthias an der Heiden, Florian van Bömmel, Markus Cornberg, Stefan Mauss, Heiner Wedemeyer, Daniel Schmidt, Sandra Dudareva
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
Externí odkaz:
https://doaj.org/article/bc5db240960347edb72c0e826a183d2c
Autor:
José Antonio Mata-Marín, Armando Abraham de Pablos-Leal, Stefan Mauss, Carla Ileana Arroyo-Anduiza, Mara Soraya Rodríguez-Evaristo, Luis Antonio Uribe-Noguéz, María de Los Ángeles Berrospe-Silva, Juan Carlos Lara-Castañeda, Edgar Pérez-Barragán, Jesús Gaytán-Martínez
Publikováno v:
PLoS ONE, Vol 17, Iss 7, p e0269977 (2022)
PurposeIn the last two decades transmission of hepatitis C virus (HCV) in HIV positive men who have sex with men (MSM) has been reported globally. Chemsex and specific sexual practices have been identified as risk factors. Our study aimed to identify
Externí odkaz:
https://doaj.org/article/c3908b72453b45a49db7422b382ab414
Autor:
Lara K Marquez, Patrick Ingiliz, Christoph Boesecke, Ivanka Krznaric, Knud Schewe, Thomas Lutz, Stefan Mauss, Stefan Christensen, Jürgen K Rockstroh, Sonia Jain, Feng He, Joel O Wertheim, Natasha K Martin
Publikováno v:
PLoS ONE, Vol 17, Iss 5, p e0267853 (2022)
BackgroundPrior to direct-acting antivirals (DAAs), HCV incidence rose among men who have sex with men (MSM) living with HIV infection in Germany despite high hepatitis C virus (HCV) treatment rates. We establish a HCV elimination modeling framework
Externí odkaz:
https://doaj.org/article/96be3329927a4248bc2fc2006f89fb95
Autor:
Monika Rau, Peter Buggisch, Stefan Mauss, Klaus H. W. Boeker, Hartwig Klinker, Tobias Müller, Albrecht Stoehr, Jörn M. Schattenberg, Andreas Geier
Publikováno v:
PLoS ONE, Vol 17, Iss 6 (2022)
Background Liver steatosis is often observed in chronic HCV infection and associated to genotype or comorbidities. NAFLD is an important risk factor for end-stage liver disease. We aimed to analyse the course of NAFLD as a concomitant disease in a co
Externí odkaz:
https://doaj.org/article/90359d06943948ee940476a5a2874203
Autor:
Anna Maisa, Christian Kollan, Matthias an der Heiden, Florian van Bömmel, Markus Cornberg, Stefan Mauss, Heiner Wedemeyer, Daniel Schmidt, Sandra Dudareva
Publikováno v:
Frontiers in Public Health, Vol 9 (2021)
Background: Germany is a low prevalence country for hepatitis B virus (HBV) infection with higher prevalence in vulnerable groups. The number of treated chronic hepatitis B (CHB) patients is unknown. We aimed to determine the number of CHB patients t
Externí odkaz:
https://doaj.org/article/5af83cccf9b8473d8926b7020169ad89
Autor:
Peter Buggisch, Hans Heiken, Stefan Mauss, Bernd Weber, Maria-Christina Jung, Herbert Görne, Renate Heyne, Holger Hinrichsen, Dennis Hidde, Bettina König, Ana Gabriela Pires Dos Santos, Claus Niederau, Thomas Berg
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0250833 (2021)
Despite the availability of highly effective and well-tolerated direct-acting antivirals, not all patients with chronic hepatitis C virus infection receive treatment. This retrospective, multi-centre, noninterventional, case-control study identified
Externí odkaz:
https://doaj.org/article/bad2952be92946c19e25d0cf762e3fcb
Autor:
Bernhard Schlevogt, Klaus H. W. Boeker, Stefan Mauss, Hartwig Klinker, Renate Heyne, Ralph Link, Karl-Georg Simon, Christoph Sarrazin, Yvonne Serfert, Michael P. Manns, Heiner Wedemeyer
Publikováno v:
Biomedicines, Vol 9, Iss 10, p 1495 (2021)
Chronic hepatitis C can be treated very effectively with direct-acting antivirals (DAA) with only minor side effects compared to an interferon-containing treatment regimen. The significance of metabolic comorbidities after HCV cure is not well define
Externí odkaz:
https://doaj.org/article/eda588095030462e95ce5bb2b8b02403
Autor:
Stefan Mauss, Stanislas Pol, Maria Buti, Erika Duffell, Charles Gore, Jeffrey V. Lazarus, Hilje Logtenberg-van der Grient, Jens Lundgren, Antons Mozalevskis, Dorthe Raben, Eberhard Schatz, Stefan Wiktor, Jürgen K. Rockstroh, on behalf of the European consensus working group on late presentation for Viral Hepatitis Care
Publikováno v:
BMC Medicine, Vol 15, Iss 1, Pp 1-5 (2017)
Abstract Introduction We present two consensus definitions of advanced and late stage liver disease being used as epidemiological tools. These definitions can be applied to assess the morbidity caused by liver diseases in different health care system
Externí odkaz:
https://doaj.org/article/b2464d88677e4b3a88691640b11e6bb6